←Search results

Search “RAG”

By relevance · Total 200 results Clear search

Thursday

Wednesday

  1. ChinaTalkSelected

    China's Ministry of Commerce plans to include AI models in the export control catalog

    China's Ministry of Commerce and Ministry of Science and Technology issued Announcement No. 48 of 2026 on October 16, proposing to add 40 items to the Catalogue of Technologies Prohibited or Restricted from Export in China, of which 14 are prohibited from export and 26 are restricted from export, and to implement pre-export registration for all newly added technologies effective immediately. The draft sets three thresholds for frontier models: ≥10^26 FLOP, ≥2T parameters, or reaching a globally leading level, and also covers AI chip design, memory chips, ten-thousand-card-level clusters, agents, AIGC detection tools, training data, and cyber offense and defense capabilities; scenarios such as open source, self-built overseas data centers, and overseas tape-out may use the report-and-export channel. The public comment period runs until November 15.

    China's Ministry of Commerce and Ministry of Science and Technology issued Announcement No. 48 of 2026 on October 16, proposing to add 40 items to the Catalogue of Technologies Prohibited or Restricted from Export in China, of which 14 are prohibited from export and 26 are restricted from export, and to implement pre-export registration for all newly added technologies effective immediately. The draft sets three thresholds for frontier models: ≥10^26 FLOP, ≥2T parameters, or reaching a globally

    Matched fieldsBody

    #analysis#English text is being prepared.#English text is being prepared.#Open-source ecosystem
  9. Analytics India Magazine

    OpenAI acquires Orchestra Bio to build AI agents for drug discovery

    OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical companies coordinate drug discovery projects; the terms of the deal were not disclosed. Orchestra Bio was founded in 2022 and had raised approximately $20 million by 2025, with investors including Andreessen Horowitz, Atria Ventures, and 8VC. Its team and technology will be integrated into OpenAI's Rosalind model and tool suite for life sciences research, and the two sides plan to develop AI agents capable of connecting scientific discovery with the research, decision-making, and workflows needed to advance drug candidates.

    OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical companies coordinate drug discovery projects; the terms of the deal were not disclosed. Orchestra Bio was founded in 2022 and had raised approximately $20 million by 2025, with investors including Andreessen Horowitz, Atria Ventures, and 8VC. Its team and technology will be integrated into OpenAI's Rosalind model and tool suite for life sciences research, and the two sides plan to develop AI agents capable of connecting s

    Matched fieldsBody

    #hot-signal#Industry news#Agents#OpenAI
  13. Analytics India MagazineSelected

    Tesla and SpaceX Form Independent Committees to Explore Merger; Musk Expresses Support

    On SpaceX's third-quarter earnings call, Musk said Tesla and SpaceX have each formed independent committees to explore a potential merger, and that he personally supports the idea, citing opportunities in AI, chip design, robotics, and connectivity technology. The two companies have not reached agreement on transaction terms, and the merger remains uncertain; Musk said the committees are composed of independent directors and that the evaluation process does not involve him, in order to avoid conflicts of interest arising from his financial interests in both companies. If the transaction proceeds, Tesla would need voting support representing 50% of all shares, not just a majority of votes cast. SpaceX's third-quarter revenue was about $14.6 billion, up 161% year over year, with net profit of $4.4 billion, and the AI business contributed significantly to growth; the two companies' joint chip manufacturing project Terafab is expected to produce its first test chip around May or June 2027, with a target of mass production in the third quarter of 2028. Reuters, citing people familiar with the matter, said the talks could also lead to SpaceX acquiring Tesla, but neither company has confirmed the transaction structure or valuation.

    On SpaceX's third-quarter earnings call, Musk said Tesla and SpaceX have each formed independent committees to explore a potential merger, and that he personally supports the idea, citing opportunities in AI, chip design, robotics, and connectivity technology. The two companies have not reached agreement on transaction terms, and the merger remains uncertain; Musk said the committees are composed of independent directors and that the evaluation process does not involve him, in order to avoid con

    Matched fieldsBody

    #hot-signal#Industry news#OpenAI

Tuesday